Samira Yadegari

Summary

Affiliation: Tehran University of Medical Sciences
Location: Tehran, Iran
Publications:
1.Idiopathic (primary) generalized epilepsy. Traditional versus new antiepileptic drugs.

Yadegari S, Bahrami P.

Neurosciences (Riyadh). 2013 Apr;18(2):117-21.

PMID:[PubMed - in process]

Select item
2.Cognitive impairments in patients with cerebrovascular risk factors: A comparison of Mini Mental Status Exam and Montreal Cognitive Assessment.

Sikaroodi H, Yadegari S, Miri SR.

Clin Neurol Neurosurg. 2013 Jan 2. doi:pii: S0303-8467(12)00604-X. 10.1016/j.clineuro.2012.11.026. [Epub ahead of print]

PMID:[PubMed - as supplied by publisher]

Select item
3.Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.

Bonab MM, Sahraian MA, Aghsaie A, Karvigh SA, Hosseinian SM, Nikbin B, Lotfi J, Khorramnia S, Motamed MR, Togha M, Harirchian MH, Moghadam NB, Alikhani K, Yadegari S, Jafarian S, Gheini MR.

Curr Stem Cell Res Ther. 2012 Nov;7(6):407-14.

PMID:[PubMed - in process]

Select item
4.Protracted disease course after deafness in a man with Brown-Vialetto-Van Laere syndrome.

Yadegari S, Razmjoo K, Nafissi S.

Neurosciences (Riyadh). 2012 Jul;17(3):253-5.

PMID:[PubMed - indexed for MEDLINE]

Select item
5.Four novel C20orf54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.

Dezfouli MA, Yadegari S, Nafissi S, Elahi E.

J Hum Genet. 2012 Sep;57(9):613-7. doi: 10.1038/jhg.2012.70. Epub 2012 Jun 21.

PMID:[PubMed - indexed for MEDLINE]

Publications

  1. doi Four novel C20orf54 mutations identified in Brown-Vialetto-Van Laere syndrome patients
    Mitra Ansari Dezfouli
    School of Biology, University College of Science, University of Tehran, Tehran, Iran
    J Hum Genet 57:613-7. 2012
  2. ncbi Protracted disease course after deafness in a man with Brown-Vialetto-Van Laere syndrome
    Samira Yadegari
    Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
    Neurosciences (Riyadh) 17:253-5. 2012
  3. ncbi Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study
    Mandana Mohyeddin Bonab
    Immunogenetics Research Centre, Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran
    Curr Stem Cell Res Ther 7:407-14. 2012
  4. doi Cognitive impairments in patients with cerebrovascular risk factors: a comparison of Mini Mental Status Exam and Montreal Cognitive Assessment
    Hajir Sikaroodi
    Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
    Clin Neurol Neurosurg 115:1276-80. 2013
  5. ncbi Idiopathic (primary) generalized epilepsy. Traditional versus new antiepileptic drugs
    Samira Yadegari
    Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
    Neurosciences (Riyadh) 18:117-21. 2013
  6. doi Approach to a patient with blepharoptosis
    Samira Yadegari
    Department of Neuro Ophthalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Ghazvin Ave, Tehran, Iran, 1336616351
    Neurol Sci 37:1589-96. 2016

Collaborators

Detail Information

Publications6

  1. doi Four novel C20orf54 mutations identified in Brown-Vialetto-Van Laere syndrome patients
    Mitra Ansari Dezfouli
    School of Biology, University College of Science, University of Tehran, Tehran, Iran
    J Hum Genet 57:613-7. 2012
    ..The causative nucleotide variations were not observed in 200 control individuals. One of the patients harbored compound heterozygous mutations, but only one mutated allele was observed in each of the two remaining patients...
  2. ncbi Protracted disease course after deafness in a man with Brown-Vialetto-Van Laere syndrome
    Samira Yadegari
    Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
    Neurosciences (Riyadh) 17:253-5. 2012
    ..Six years later, he had gradual worsening and death. Along with potential new developing therapeutic options, this case emphasizes considering the diagnosis of BVVLS especially after a long period of stability, even in men...
  3. ncbi Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study
    Mandana Mohyeddin Bonab
    Immunogenetics Research Centre, Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran
    Curr Stem Cell Res Ther 7:407-14. 2012
    ..Repeating the study with a larger sample size, booster injections and longer follow-up using a controlled study design is advised...
  4. doi Cognitive impairments in patients with cerebrovascular risk factors: a comparison of Mini Mental Status Exam and Montreal Cognitive Assessment
    Hajir Sikaroodi
    Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
    Clin Neurol Neurosurg 115:1276-80. 2013
    ..The study aim was to compare Montreal Cognitive Assessment (MoCA) and MMSE tests in subjects with cerebrovascular risk factors...
  5. ncbi Idiopathic (primary) generalized epilepsy. Traditional versus new antiepileptic drugs
    Samira Yadegari
    Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
    Neurosciences (Riyadh) 18:117-21. 2013
    ..In the proper management of IGE, neurologists should consider the predominant seizure type, patient gender, co-morbidities, and antiepileptic drugs that may aggravate a specific seizure type...
  6. doi Approach to a patient with blepharoptosis
    Samira Yadegari
    Department of Neuro Ophthalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Ghazvin Ave, Tehran, Iran, 1336616351
    Neurol Sci 37:1589-96. 2016
    ..Considering some features, such as involvement of other cranial nerves, extraocular muscle, pupil size and reactivity, and unilateral or bilateral presentation of ptosis, could help to narrow the differential diagnosis. ..